Log In
person
Nektar Therapeutics
NKTR
summarize
3 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Autoimmune Pharmaceuticals |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
68.92M | 76.48% |
| Autoimmune Pharmaceuticals |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
20.68M | 22.95% |
| Autoimmune Pharmaceuticals |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
0.52M | 0.58% |
| keyboard_arrow_down |
Autoimmune Pharmaceuticals
Pharmaceutical Patent Licensing
|
68.92M | 76.48% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Autoimmune Pharmaceuticals
Branded Pharmaceuticals
|
20.68M | 22.95% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Autoimmune Pharmaceuticals
Pre-Revenue Pharmaceuticals
|
0.52M | 0.58% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||